Quick Answer
Chemomab Therapeutics Ltd. reported Common Stock Shares Outstanding of 37.10 million shares for the year ending 2020.
- Chemomab Therapeutics Ltd. showed an increase of +0.0% in Common Stock Shares Outstanding from 2019 to 2020.
- This data is from Chemomab Therapeutics Ltd.'s annual report (Form 10-K), filed with the SEC on March 9, 2021.
- XBRL data for this metric is available from 2018 to 2020 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2018 to 2020), Chemomab Therapeutics Ltd.'s Common Stock Shares Outstanding has grown by 138.2%.
- Historical annual values: Fiscal year 2020: 37.10 million shares | Fiscal year 2019: 37.10 million shares | Fiscal year 2018: 15.58 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: